95301 ⎘
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS
#2102Prodrugs of riluzole and their method of use
#2103Compounds and methods for inducing browning of white adipose tissue
#2104Aminoquinazoline compounds as Aantagonist
#2105Riluzole prodrugs and their use
#2106Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#2107Process for the preparation of 1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2s)-2-[(methyl{[2-(propan-2-yl)-1,3-thiazol-4YL] methyl} carbamoyl) amino]-4-(morpholin-4-yl)butanoyl]amino)-1,6-diphenylhexan-2-yl]carbamate
#2108Factor IXa inhibitors
#2109Quinazolines as potassium ion channel inhibitors
#2110Modulators of indoleamine 2,3-dioxygenase and methods of using the same
#2111PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING
#2112Compounds for treatment of complement mediated disorders
#2113Ether compounds for treatment of complement mediated disorders
#2114Compounds, compositions and methods
#2115Autotaxin inhibitors
#2116COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES
#21173-substituted cyclopentylamine derivatives
#2118Compounds for the treatment of hepatitis C
#2119Polymerizable compound and optical isomer
#2120Therapeutic compounds and uses thereof
#2121Cannabinoid receptor mediating compounds
#2122Cannabinoid receptor mediating iminopyrazole compounds
#2123GLP-1 receptor modulators
#2124Compounds having estrogen receptor alpha degradation activity and uses thereof
#2125CYCLIC PROTEIN TYROSINE KINASE INHIBITORS
#2126METHODS FOR TREATING VASCULAR LEAK SYNDROME
#2127Herbicidal phenylpyridines
#2128Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
#2129Conjugated polymers based on terthiophene and their applications
#2130Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
#2131Chromenone inhibitors of monocarboxylate transporters
#2132Quinazoline and quinoline compounds and uses thereof
#2133Anthelmintic compounds, compositions and method of using thereof
#2134Immunomodulator compounds
#2135T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
#2136Tricyclic sulfones as RORγ modulators
#2137Tricyclic spiro compound
#21385-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
#2139USE OF PICOLINAMIDES AS FUNGICIDES
#2140N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as Wnt signaling modulators
#2141Hydrazone derivatives for the treatment of cancer
#2142Zinc complexes of hydrazones and (thio)semicarbazones and their use for the treatment of cancer
#2143Picolinamides as fungicides
#2144Polymerizable compound and optically anisotropic object
#2145Iminothiadiazine dioxides bearing an amine-linked substituent as BACE inhibitors, compositions, and their use
#2146Aryl sulfonamides
#2147Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis
#2148Compounds, compositions, and methods for increasing CFTR activity
#2149Modulation of Bacterial Quorum Sensing with Synthetic Ligands
#2150MONOCYCLIC HETEROARYL COMPOUNDS
#2151INHIBITORS OF HISTONE DEMETHYLASES
#2152Treatment or prophylaxis of proliferative conditions
#2153POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY
#2154Process and intermediates for making tubulysin analogs
#21551-methylpyrazole-piperazine compounds having multimodal activity against pain
#2156Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis
#2157PRO-SURVIVAL COMPOUNDS
#2158Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#2159N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2- trifluoroacetamide for control of agricultural/horticultural pests
#2160C-met modulators and methods of use
#2161Peripherally substituted monocyclic beta-lactams
#2162Process for the preparation of lurasidone and its intermediate
#2163Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections
#2164Inhibitors of lysine gingipain
#2165N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer
#2166Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
#2167ULK1 inhibitors and methods using same
#2168Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
#2169LIGANDS FOR ANTIBODY AND FC-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMOTOGRAPHY IV
#2170Method of preparing glucosylceramide synthase inhibitors
#2171Benzenesulfonamide compounds and their use as therapeutic agents
#2172AMINO-SUBSTITUTED ISOTHIAZOLES
#2173Prodrugs of riluzole and their method of use
#2174Mitochondrial uncouplers for treatment of metabolic diseases and cancer
#2175Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
#2176Pesticidally active amide heterocyclic derivatives with sulphur containing substituents
#2177CXCR7 receptor modulators
#2178Compounds and methods for the targeted degradation of androgen receptor
#2179Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
#2180Derivatives of 2-(1,2,4-triazol-3-ylsulfanyl)-N-1,3,4-thiadiazol-2-yl acetamide which are useful for the treatment of inter alia diabetes
#2181(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
#2182Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
#2183HIV replication inhibiting pyrimidines
#2184Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
#2185Compositions and methods for treating ocular diseases
#2186METHODS AND DRUG PRODUCTS FOR TREATING ALZHEIMER'S DISEASE
#21872-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors
#2188COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#2189GLP-1 receptor modulators
#2190Diheteroaryl histone deacetylase inhibitors and their use in therapy
#2191Modulators of calcium release-activated calcium channel
#2192Compounds and methods for the treatment of cystic fibrosis
#21932-amino-3,5-difluoro-3,6-dimethyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treating alzheimer's disease
#2194Herbicidal compounds
#2195Polymerizable compound and optically anisotropic body
#2196Substituted aminothiazoles for the treatment of tuberculosis
#2197Heterocyclic compounds as pesticides
#2198N-ACYLPIPERIDINE ETHER TROPOMYOSIN-RELATED KINASE INHIBITORS
#2199SMALL MOLECULE INHIBITORS OF NECROPTOSIS
#2200Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
#2201Amide compounds for treatment of complement mediated disorders
#2202Glycosidase inhibitors
#2203Tetrahydroisoquinoline derived PRMT5-inhibitors
#2204HETEROCYCLIC RING AND CARBOCYCLIC DERIVATIVE
#2205Deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams
#2206SMALL MOLECULE INHIBITORS OF HIV-1 ENTRY AND METHODS OF USE THEREOF
#2207Compositions and methods for inhibition of the JAK pathway
#2208ARYL SULTAM DERIVATIVES AS RORc MODULATORS
#2209Therapeutic compounds as inhibitors of the orexin-1 receptor
#22101,2,4-triazine-4-amine derivatives
#2211Small molecule regulators of steroid receptor coactivators and methods of use thereof
#22122-aminothiazole derivative or salt thereof
#2213Glutaminase inhibitors
#2214URAT1 inhibitor
#2215Compounds for the treatment of paramyxovirus viral infections
#22161,2,3-thiadiazol-5yl-urea derivatives, use thereof for regulating plant senescence and preparations containing these derivatives
#2217Benzenesulfonyl-asymmetric ureas and medical uses thereof
#2218Indazole compounds as FGFR kinase inhibitor, preparation and use thereof
#2219BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS
#2220Isoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
#22211,3,4-THIADIAZOLES HAVING A HERBICIDAL ACTIVITY, THEIR AGRONOMICAL COMPOSITIONS AND RELATIVE USE
#2222Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
#2223Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
#2224CYCLOPROPYL FUSED THIAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
#2225SUBSTITUTED URACILS AS CHYMASE INHIBITORS
#2226Pyrazolyl guanidine FF-ATPase inhibitors and therapeutic uses thereof
#2227Compounds, compositions and methods
#2228Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C
#2229Biaryl amide compounds as kinase inhibitors
#2230Androgen receptor modulating compounds
#2231S-imino-S-oxo iminothiazine compounds as bace inhibitors, compositions, and their use
#2232Heterocyclic compound
#2233Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II
#2234Thiazolidinone compounds and use thereof
#2235Aryl-or heteroaryl-substituted benzene compounds
#2236N4-PHENYL-QUINAZOLINE-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
#2237Inhibitors of IRAK4 activity
#2238SUBSTITUTED 4-ALKOXYPICOLINAMIDE ANALOGS AS MGLUR5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME
#2239Compounds
#2240Substituted Pyrrolidine Carboxamide Compounds
#2241C5-C6-fused tricyclic iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
#22422,4-pyrimidinediamine compounds and their uses
#2243Process for the preparation of Lurasidone hydrochloride
#22443-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1)-one derivatives as fungicides
#2245Thiazolyl-containing compounds for treating proliferative diseases
#2246Crystalline forms of a BACE inhibitor, compositions, and their use
#2247PROCESSES FOR THE PREPARATION OF A BACE INHIBITOR
#2248Dual mechanism inhibitors for the treatment of disease
#2249Compounds as ROR gamma modulators
#2250Compounds, compositions, and methods for increasing CFTR activity
#2251Heterocyclic compounds as NaV channel inhibitors and uses thereof
#2252HSP70 modulators and methods for making and using the same
#2253SUBSTITUTED QUINOLINE-4-CARBOXAMIDES AND USE THEREOF
#2254Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof
#2255IDO inhibitors
#2256Compounds, compositions and methods
#2257PHTHALAZINONE DERIVATIVES
#2258CXCR4 receptor antagonists
#2259Quinazoline derivative
#2260Crystalline forms of a BACE inhibitor, compositions, and their use
#2261Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
#2262Pyrimidine-2,4-diamine derivatives for treatment of cancer
#2263Bicyclo[3.2.1]Octyl Amide Derivatives and Uses of Same
#22644-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
#2265Class of mu-opioid receptor agonists
#2266Aminopyrimidine derivatives for use as modulators of kinase activity
#2267SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
#2268Deoxycytidine kinase inhibitors
#2269MTH1 inhibitors for treatment of cancer
#2270Immunoregulatory agents
#22713-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
#2272Bifunctional compounds and use for reducing uric acid levels
#2273Estrogen receptor modulators and uses thereof
#2274MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#2275Compositions useful in treating brain-related diseases or disorders and methods using same
#2276BIS(ARYL)CATECHOL DERIVATIVES AS HERBICIDES
#2277Pyrazole compounds and methods of making and using same
#2278Amino compounds for treatment of complement mediated disorders
#2279Tetrahydroisoquinolin-1-one derivative or salt thereof
#2280TRPV1 antagonists including dihydroxy substituent and uses thereof
#2281Sweet flavor modifier
#2282Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
#2283Dasatinib salts
#2284Heterocyclic amides as kinase inhibitors
#2285Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
#2286Therapeutic compounds and compositions
#2287LSD1 inhibitors
#2288Quinoxaline compounds and uses thereof
#2289Quinoline derivatives as SMO inhibitors
#2290Protein kinase conjugates and inhibitors
#2291Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels
#2292Pyridazine compounds as JAK inhibitors
#2293Anti-amyloid compounds containing benzofurazan
#2294Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
#2295Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
#2296Apelin receptor (APJ) agonists and uses thereof
#2297Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
#2298Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
#2299N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
#2300Pyrimidinone derivative having autotaxin-inhibitory activity
#2301TrKA kinase inhibitors, compositions and methods thereof
#2302Compounds and methods for inhibiting fascin
#2303Substituted pyrimidines for inhibiting Raf kinase activity
#2304Histone demethylase inhibitors
#2305Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient
#2306Heterocyclic compounds, process for preparation of the same and use thereof
#2307Quinazolinone derivatives as PARP inhibitors
#2308Method for producing pyridine compound
#2309Vinylogous thioester compounds and methods of use
#2310Insecticidal compounds based on isoxazoline derivatives
#2311Amino quinazolines as kinase inhibitors
#2312NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND
#2313Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same
#2314STING AGONISTS AND METHODS OF SELECTING STING AGONISTS
#2315Substituted asymmetric ureas as modulators of ghrelin receptor activity
#2316HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL
#2317Use of substituted oxadiazoles for combating phytopathogenic fungi
#2318Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections
#2319Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#2320Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
#2321Tetrazole-substituted arylamides as PXand PXantagonists
#23226-amino-5,6,7,8-tetrahydronaphthalen-2-yl or 3-aminochroman-7-yl derivatives
#2323SULFONAMIDE COMPOUNDS AS VOLTAGE GATED SODIUM CHANNEL MODULATORS
#2324Chemokine CXCR4 and CCR5 receptor modulators and uses related thereto
#2325Aryl sultam derivatives as RORc modulators
#2326Ribonucleotide reductase inhibitors and methods of use
#2327Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway
#2328TRPM8 antagonists
#23296-acyl-1,2,4-triazine-3,5-dione derivative and herbicides
#2330Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2
#2331Anti-fibrotic pyridinones
#2332HIV REPLICATION INHIBITING PYRIMIDINES
#2333COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
#2334Complexes
#2335Aryl- or heteroaryl-substituted benzene compounds
#2336TrkA kinase inhibitors, compositions and methods thereof
#2337PRMT5 inhibitors and uses thereof
#2338NOVEL EFFECTIVE ANTIVIRAL COMPOUNDS AND METHODS USING SAME
#2339Histone demethylase inhibitors
#2340Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
#2341Dihydroxy aromatic heterocyclic compound
#2342Compounds useful as immunomodulators
#2343Indole derivatives for use in medicine
#2344Substituted prolines/piperidines as orexin receptor antagonists
#2345Isothiazole derivatives as CFTR modulators
#2346Carboxamide derivatives and use thereof
#2347Pyrazole-substituted arylamides as P2Xand P2Xantagonists
#2348DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#2349Heteroaryl sulfonamides and CCR2/CCR9
#2350Fused heterocyclic compounds as ion channel modulators
#2351Insecticidally active amide derivatives with sulfur-substituted phenyl or pyridine groups
#23522,4-pyrimidinediamine compounds and their uses
#2353Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists
#2354DIHYDROTHIAZINE AND DIHYDROOXAZINE DERIVATIVES HAVING BACE1 INHIBITORY ACTIVITY
#2355Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
#2356Human plasma kallikrein inhibitors
#2357Benzomorphan analogs and use thereof
#2358Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replication
#2359Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#2360Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#2361Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell
#23622-Amino-3,5,5-Trifluoro-3,4,5,6-Tetrahydropyridines as BACE1 Inhibitors for Treatment of Alzheimer's Disease
#2363Mitotic kinesin inhibitors and methods of use thereof
#2364Small molecule fatty acid synthase inhibitors
#2365Urea derivative or pharmacologically acceptable salt thereof
#2366Isoxazoline-substituted benzamide compound and pesticide
#2367Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#2368Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#2369Anti-viral compounds, pharmaceutical compositions, and methods of use thereof
#2370Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
#2371Compounds for treatment of cancer
#2372Compounds and methods for kinase modulation, and indications therefor
#23733-CYCLOALKYLAMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS
#2374Inhibitors of RPN11
#2375Benzamide compounds and related methods of use
#2376Sulfur derivatives as chemokine receptor modulators
#23775-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same
#23782-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors
#2379Iminothiadiazepane dioxide compounds as BACE inhibitors, compositions, and their use
#2380Amide derivatives and pharmaceutically acceptable salts thereof, preparation method thereof and medicinal application thereof
#2381SUBSTITUTED 2-(CHROMAN-6-YLOXYL)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS
#2382Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor I
#2383GUANIDINE COMPOUNDS AND USE THEREOF AS BINDING PARTNERS FOR 5-HT5 RECEPTORS
#2384COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
#2385Heterocyclic compounds and uses thereof
#2386Cyclopropanamine compound and use thereof
#2387Sweet flavor modifier
#2388Tetrahydro-benzoimidazolyl modulators of TGR5
#2389INSECTICIDAL COMPOUNDS
#2390Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
#2391Benzamides
#2392HDMX inhibitors and their use for cancer treatment
#2393Prodrugs of NH-acidic compounds
#2394Hepatitis B core protein allosteric modulators
#2395Compound having selective EP2 agonist activity
#2396SUBSTITUTED PYRAN DERIVATIVES
#2397Heteroaryl butanoic acid derivatives
#2398PKM2 modulators and methods for their use
#2399PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING
#2400Hepatitis B antiviral agents